Investigations into eIF4B and eIF4H expression in patient-derived cells and in post-mortem tissue revealed that eIF4H is significantly downregulated in ALS/FTD patients harboring the G4C2 expansion (C9+ ALS/FTD) (see Fig. 6). This evidence concerns the gene EIF4H and frontotemporal dementia.